[vc_row css=".vc_custom_1499116817279{background-image: url(http://swerve.fyi/wp-content/uploads/2017/04/Deer1RoadMapheader5.jpg?id=3427) !important;}"][vc_column width="1/12"][/vc_column][vc_column width="10/12"][vc_column_text][spacer height="-2px"]
<img class="aligncenter size-full wp-image-4511" src="http://swerve.fyi/wp-content/uploads/2017/04/THCHeaderResources4.jpg" alt="" width="1280" height="250" />

<strong><span style="font-size: 24px;">Resources</span></strong>

<hr />

&nbsp;

<img class="size-full wp-image-4700 alignleft" src="http://swerve.fyi/wp-content/uploads/2017/04/tree.png" alt="" width="160" height="160" />Cannabinoid VR offers helpful and reliable information and resources about cannabis, its therapeutic potential to treat a variety of conditions, research studies, access and general guidance about the Access to Cannabis for Medical Purposes (ACMPR) system in Canada.

The cannabis plant has been used for thousands of years to treat various ailments in ancient China, India and Greece. More recently, there has been a torrent of interest in this complex plant that has garnered the attention of researchers, health practitioners and patients across North America and internationally.

On August 11, 2016, Health Canada announced the new <span style="color: #800000;"><em><a style="color: #800000;" href="http://laws-lois.justice.gc.ca/eng/regulations/SOR-2016-230/index.html">Access to Cannabis for Medical Purposes Regulations</a></em></span> (ACMPR).

<span class="cwgf-standard-line-height">The ACMPR came into force on August 24, 2016. These regulations replace the <em>Marihuana for Medical Purposes Regulations</em> (MMPR) as of August 24, 2016, and are being implemented as a result of the Federal Court ruling in the case of <em>Allard v. Canada</em>. The ACMPR allow for reasonable access to cannabis for medical purposes for Canadians who have been authorized to use cannabis for medical purposes by their health care practitioner.
</span>

<strong>Medical Conditions</strong>
<p style="padding-left: 30px;">Your health care practitioner may have authorized the use of cannabis (marihuana, marijuana) for the relief of one or more of the following symptoms associated with a variety of disorders which have not responded to conventional medical treatments. These symptoms (or conditions) may include: severe refractory nausea and vomiting associated with cancer chemotherapy; loss of appetite and body weight in cancer patients and patients with HIV/AIDS; pain and muscle spasms associated with multiple sclerosis; chronic non-cancer pain (mainly neuropathic); severe refractory cancer-associated pain; insomnia and depressed mood associated with chronic diseases (HIV/AIDS, chronic non-cancer pain); and symptoms encountered in the palliative/end-of-life care setting. This is not an exhaustive list of symptoms or conditions for which cannabis may be authorized for use by your health care practitioner.
~ <em><span style="color: #800000;"><a style="color: #800000;" href="http://www.hc-sc.gc.ca/dhp-mps/marihuana/info/cons-eng.php" target="_blank">Health Canada</a></span></em></p>
Treatment decisions are best made in consultation with your health care practitioner. Under the ACMPR, an authorized health care practitioner includes physicians in all provinces and territories, and nurse practitioners in provinces and territories where supporting cannabis for medical purposes is permitted under their scope of practice.

&nbsp;

&nbsp;

&nbsp;

<hr />

<strong>Disclaimer:</strong> The material on this website is provided for educational and informational purposes only, and is not intended to be a substitute for a health care provider's consultation. Please consult your own appropriate health care provider about the applicability of any opinions or recommendations with respect to your own symptoms or medical conditions. The information herein does not constitute health, legal or technical advice.[/vc_column_text][/vc_column][vc_column width="1/12"][/vc_column][/vc_row]